Skip to main content
Log in

The pharmacokinetics of a slow-release theophylline preparation in horses after intravenous and oral administration

  • Pharmacology
  • Published:
Veterinary Research Communications Aims and scope Submit manuscript

Abstract

The pharmacokinetics of a slow-release theophylline formulation was investigated following intravenous and oral administration at 10 mg/kg in horses. A tricompartmental model was selected to describe the intravenous plasma profile. The elimination half-life (t1/2β) was 16.91 ± 0.93 h, the apparent volume of distribution (V d) was 1.35 ± 0.18 L/kg and the body clearance (ClB) was 0.061 ± 0.009 L kg−1 h. After oral administration the half-life of absorption was 1.24 ± 0.30 h, and the calculated bioavailability was above 100%. Thet1/2β after oral administration was 18.51 ± 1.75 h, only a little longer than that after intravenous administration. The slow release formulation did not exhibit any advantage in prolonging thet1/2β of theophylline in the horse.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Akaike, H., 1976. An information criterion (AIC).Mathematical Science,14, 5–9

    Google Scholar 

  • Ayres, J., Pearson, E., Riebold, T. and Chang, S., 1985. Theophylline and diphylline pharmacokinetics in the horse.American Journal of Veterinary Research,46, 2500–2506

    PubMed  Google Scholar 

  • Beech, H., 1979. Principles of therapy.Veterinary Clinics of North America. Large Animals Practice,1, 73–88

    Google Scholar 

  • D'Argenio, D. and Schumitzky, A., 1979. A program package for simulation and parameter estimation in pharmacokinetic systems.Computer Programs in Biomedicine,9, 115–134

    PubMed  Google Scholar 

  • Davis, L.E., 1980. Applied pharmacodynamics of digitalis, theophylline, diuretics and selected antiarrythmics drugs. In: R.W. Kirk (ed),Current Veterinary Therapy VII. Small Animal Practice, (W.B. Saunders, Philadelphia), 352–359

    Google Scholar 

  • Davis, L.E., Neff Davis, C., Koritz, G.D., Bevill, R.F., Sharma, G.C., Langston, V.C. and Munsiff, I.J., 1987. Effect of organic vehicles in pharmacokinetics of aminophylline administered intravenously to goats.Journal of Veterinary Pharmacology and Therapeutics,10, 144–149

    PubMed  Google Scholar 

  • Derksen, F.J., 1983. Chronic airway disease. In: E. Robinson (ed),Current Therapy in Equine Medicine, (W.B. Saunders, Philadelphia), 509

    Google Scholar 

  • Errecalde, J.O., Button, C., Baggot, J.D. and Mulders, M.S.G., 1984. Pharmacokinetics and bioavailability of theophylline in horses.Journal of Veterinary Pharmacology and Therapeutics,7, 255–264

    PubMed  Google Scholar 

  • Hendeles, L. and Weinberger, M., 1982. Improved efficacy and safety of theophylline in the control of airways hyperactivity.Annals of Allergy,49, 247–256

    PubMed  Google Scholar 

  • Ingvast-Larson, C., Paalzow, L., Ottosson, T. and Appelgreen, L.E., 1985. Pharmacokinetic studies of theophylline in horses.Journal of Veterinary Pharmacology and Therapeutics,8, 76–81

    PubMed  Google Scholar 

  • Jacobs, M.H., Senior, R.M. and Kessler, G., 1976. Clinical experience with theophylline: relationship between dosage, serum concentration and toxicity.Journal of the American Medical Association,235, 1983–1986

    PubMed  Google Scholar 

  • Jenne, J.W., Wyze, E., Rood, F.S. and McDonald, F.M., 1972. Pharmacokinetics of theophylline: application to adjustment of the clinical dose of theophylline.Clinical Pharmacology and Therapeutics,13, 349–360

    PubMed  Google Scholar 

  • Koritz, G., Borne, D., Hunt, J. and Prasad, V., 1981. Pharmacokinetics of theophylline in swine: a potential model for human drug bioavailability studies.Journal of Veterinary Pharmacology and Therapeutics,4, 233–239

    PubMed  Google Scholar 

  • Koritz, G., McKiernan, B. and Neff Davies, C., 1986. Bioavailability of four slow release formulations in the Beagle dog.Journal of Veterinary Pharmacology and Therapeutics,9, 293–302

    PubMed  Google Scholar 

  • Kowalczyk, D.F., Beech, J. and Littlejohn, D., 1984. Pharmacokinetic disposition of theophylline in horses after intravenous administration.American Journal of Veterinary Research,45, 2272–2275

    PubMed  Google Scholar 

  • McKiernan, B.C. and Koritz, G.D., 1990. Plasma theophylline concentration and lung function in ponies with recurrent obstructive lung disease.Equine Veterinary Journal,22, 194–197

    PubMed  Google Scholar 

  • McKiernan, B.C., Neff Davis, C., Koritz, G.D. and Pheris, D., 1981. Pharmacokinetic studies of theophylline in dogs.Journal of Veterinary Pharmacology and Therapeutics,4, 103–110

    PubMed  Google Scholar 

  • McKiernan, B.C., Koritz, G.D., Davis, E. and Munsiff, I., 1983. Pharmacokinetic studies of theophylline in cats.Journal of Veterinary Pharmacology and Therapeutics,6, 99–104

    PubMed  Google Scholar 

  • Mitenko, P. and Ogilvie, R., 1973. Rational intravenous doses of theophylline.New England Journal of Medicine,289, 600–603

    PubMed  Google Scholar 

  • Nelder, J. and Mead, R., 1965. A simplex method for function minimization.Computers Journal,4, 300–313

    Google Scholar 

  • Pollock, J., Kiechel, F., Cooper, D. and Weinberger, M., 1977. Relationship of serum theophylline concentration to inhibition of exercise induced bronchospasm and comparison with chromolyn.Pediatrics Springfield,60, 840–844

    Google Scholar 

  • Rall, T.W., 1980. The xanthines. In: A.G. Gilman, L.S. Goodman and A. Gilman (eds),The Pharmacological Basis of Therapeutics, 6th edn, (McMillan, New York), 592–607

    Google Scholar 

  • Short, C.R., Horner, M.W., Blay, P.K., Moss, M.S., Edington, N. and Clarke, C.R., 1986. The lack of effect of inoculation with equine influenza vaccine on theophylline pharmacokinetics in the horse.Journal of Veterinary Pharmacology and Therapeutics,9, 426–432

    PubMed  Google Scholar 

  • Thomson, J.R. and McPherson, E.A., 1983. Chronic obstructive pulmonary disease in the horse 2: Therapy.Equine Veterinary Journal,15, 207–210

    PubMed  Google Scholar 

  • Wade, A., 1977. InMartindale, The Extra Pharmacopoeia, 27th edn, (Pharmaceutical Press, London)

    Google Scholar 

  • Wagner, J.G., 1983.Farmacocinética Clínica, (Reverté, Barcelona, Spain), 175–232

    Google Scholar 

  • Yamaoka, K., Nakagawa, T. and Uno, T., 1978. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.Journal of Pharmacokinetics and Biopharmaceutics,6, 165–175

    PubMed  Google Scholar 

  • Ziment, I., 1978. Phosphodiesterase inhibitors.Respiratory Pharmacology and Therapeutics, (W.B. Saunders, Philadelphia), 190–207

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Errecalde, J.O., Landoni, M.F. The pharmacokinetics of a slow-release theophylline preparation in horses after intravenous and oral administration. Vet Res Commun 16, 131–138 (1992). https://doi.org/10.1007/BF01839010

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01839010

Keywords

Navigation